Our client, AprilBio, needed to confidentially connect with prospective licensees interested in licensing of its novel and well-differentiated asset which offers significant potential across a wide array of neuroimmune diseases. Information disclosed included proprietary and sensitive information such as preclinical data and exclusive R&D findings for new, potent therapies. Using a general-purpose file sharing service was deemed unacceptably risky.
Find out why AprilBio selected DFIN’s Venue® Virtual Data Room solution for this project.
